Home › Therapeutic areas › Neurology › Dravet Syndrome
Dravet Syndrome (3 companies)
Companies with an active program in Dravet Syndrome.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Mkt cap | Programs |
|---|---|---|---|---|---|---|
| HRMY | Harmony Biosciences | MetabolicNeurology Rare | 1 | Approved | $1.94B | 17 |
| STOK | Stoke Therapeutics | Neurology Rare | 1 | Phase 3 | $1.74B | 2 |
| XENE | Xenon Pharmaceuticals | Neurology Rare | 1 | NDA Submitted | $3.79B | 9 |
No companies match.